Search Within

Melanoma Disease Management Team

Formats
  1. Journal Article (1604)
  2. Meeting Abstract (791)
  3. Book Section (104)
  4. Review (72)
  5. Editorial (58)
  6. Research Letter (45)
  7. Guidelines (26)
  8. Conference Paper (22)
  9. Correspondence (21)
  10. Miscellaneous (16)
  11. Book Whole (11)
Groups
  1. Department of Medicine (1690)
  2. Survivorship Research (1193)
  3. Solid Tumor Oncology Division (1052)
  4. Department of Pathology and Laboratory Medicine (957)
  5. Surgery (947)
  6. Melanoma and Immunotherapeutics Service (793)

More Groups

People
  1. Klaus Busam (698)
  2. Daniel Coit (543)
  3. Allan Halpern (401)
  4. Michael Postow (369)
  5. Alexander Shoushtari (247)
  6. Jedd Wolchok (222)

More People

Years
  1. 2025 (89)
  2. 2024 (138)
  3. 2023 (160)
  4. 2022 (167)
  5. 2021 (149)
  6. 2020 (142)

More Years

Publications
  1. Journal of Clinical Oncology (269)
  2. Annals of Surgical Oncology (221)
  3. Journal of the American Academy of Dermatology (123)
  4. Journal of Investigative Dermatology (84)
  5. Modern Pathology (67)
  6. American Journal of Surgical Pathology (64)

More Publications

Publishers
  1. Springer (341)
  2. American Society of Clinical Oncology (284)
  3. Elsevier Inc. (231)
  4. Lippincott Williams & Wilkins (229)
  5. Wiley Blackwell (162)
  6. Elsevier Science, Inc. (160)

More Publishers

Results (2770)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Radiotherapy for distant melanoma metastases
    Book Section

    Hong, A. M.; Barker, C. A.; Balch, C. M.; Atkins, M. B.; Garbe, C.; Gershenwald, J. E.; Halpern, A. C.; Kirkwood, J. M.; McArthur, G. A.; Thompson, J. F.; more... Cutaneous Melanoma. 6th ed (2020)

    Fulltext@MSK | Save
  • Neck dissection and parotidectomy for melanoma
    Book Section

    Gastman, B.; Knackstedt, R.; Goepfert, R. P.; Sumer, B.; Shaha, A.; Kupferman, M. E.
    In Balch, C. M.; Atkins, M. B.; Garbe, C.; Garbe, C.; Gershenwald, J. E.; Halpern, A. C.; Kirkwood, J. M.; McArthur, G. A.; Thompson, J. F.; Sober, A. J. (Eds.) Cutaneous Melanoma. 6th ed (2020)

    Fulltext@MSK | Save
  • Cutaneous melanoma. 6th ed
    Book Whole


    Springer (2020)

    Fulltext@MSK | Save
  • Melanoma brain metastasis: Presentation, treatment and outcomes in the age of targeted- and immuno-therapies
    Meeting Abstract

    Bander, E. D.; Yuan, M.; Carnevale, J. A.; Reiner, A. S.; Panageas, K. S.; Postow, M. A.; Tabar, V.; Moss, N. S.
    Neuro-Oncology Advances (2020)

    Fulltext@MSK | Save
  • A pilot study evaluating lenalidomide and CC-486 in combination with radiotherapy for patients with plasmacytoma (LENAZART study)
    Meeting Abstract

    Shah, U. A.; Werner, K.; Tavitian, E.; Devlin, S.; Mailankody, S.; Korde, N.; Hultcrantz, M.; Tan, C.; Lu, S. X.; Smith, E. L.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • KITE-439: A phase I study of HPV16 E7 T cell receptor-engineered T cells in patients with relapsed/refractory HPV16-positive cancers
    Meeting Abstract

    Kirtane, K.; Massarelli, E.; Hanna, G. J.; Klebanoff, C. A.; Blumenschein, G.; Bishop, M. R.; Lee, S.; Niu, J.; Adhikary, S.; Astrow, S. H.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Correlative analysis of pharmacokinetics and pharmacodynamics of RGX-104, a first-in-class Liver-X-Receptor (LXR) agonist, and clinical outcomes in patients with advanced solid tumors
    Meeting Abstract

    Mita, M.; Mita, A.; Hamilton, E.; Falchook, G. S.; Postow, M.; Chmielowski, B.; Schilder, R. J.; Strauss, J.; Lim, E.; Pant, S.; more...
    Cancer Research (2020)

    Fulltext@MSK | Save
  • Survival impact of anti-GD2 antibody response - A phase II ganglioside vaccine trial in relapsed neuroblastoma
    Meeting Abstract

    Cheung, I. Y.; Cheung, N. K. V.; Modak, S.; Mauguen, A.; Basu, E.; Roberts, S. S.; Ragupathi, G.; Kushner, B. H.
    Cancer Research (2020)

    Fulltext@MSK | Save
  • Updated clinical data from the melanoma expansion cohort of an ongoing ph1/1b study of eganelisib (formerly IPI-549) in combination with nivolumab
    Meeting Abstract

    Postow, M.; Sullivan, R.; Cohen, E.; Gutierrez, M.; Hong, D.; Steuer, C.; McCarter, J.; Zizlsperger, N.; Kutok, J.; O'Connell, B.; more...
    Journal for ImmunoTherapy of Cancer (2020)

    Fulltext@MSK | Save
  • MK-3475-U02: Phase 1/2 study of investigational agents with or without pembrolizumab versus pembrolizumab monotherapy in melanoma
    Meeting Abstract

    Dummer, R.; Long, G. V.; Pavlick, A.; Postow, M.; Ribas, A.; Robert, C.; Scolyer, R. A.; Taube, J.; Tetzlaff, M.; Liao, J.; more...
    Journal for ImmunoTherapy of Cancer (2020)

    Fulltext@MSK | Save